Laura Eaton-Jankov has been safely getting new products to market with scientific evidence, high-quality care, and strong clinical data for over 20 years. She has directed over 60 global clinical trials and has been involved with the submission and support of multiple FDA applications leading to the approval of 13 class III medical devices from companies like Allergan, Evolus, Apollo Endosurgery, Teoxane Geneva (RHA), ReShape Medical (Lap-Band) and more. She has extensive experience with the development and execution of global clinical trial strategies ranging from pre-clinical testing to large-scale post-marketing registries.
UltaMed participates in all phases of clinical research across multiple therapeutic areas and welcomes new studies in both medical device and pharmaceuticals. If you are interested in joining our database of potential research subjects please complete the interest form below.
